glp-1 agonists thyroid cancer Ozempic and Wegovy increase risk of cancer. “Use of RA for 1-3 years was associated with increased risk of all thyroid (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) risk of medullary thyroid cancer
Pay in 4 interest-free payments of $6.26 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
![glp-1 agonists thyroid cancer Ozempic and Wegovy increase risk of cancer. Use of RA for 1-3 years was associated with increased risk of all thyroid (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) risk of medullary thyroid cancer](https://cdn.sanity.io/images/0vv8moc6/cancernetwork/a065c5642434c3bb4dc65769d00c10ad32045514-1080x1920.png)
![glp-1 agonists thyroid cancer Ozempic and Wegovy increase risk of cancer. Use of RA for 1-3 years was associated with increased risk of all thyroid (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) risk of medullary thyroid cancer](https://www.musechem.com/wp-content/uploads/2026/07/109c9670-806d-42f9-b57f-fa9af870deb0.png)
![glp-1 agonists thyroid cancer Ozempic and Wegovy increase risk of cancer. Use of RA for 1-3 years was associated with increased risk of all thyroid (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) risk of medullary thyroid cancer](https://assets.medpagetoday.net/media/images/109xxx/109609.jpg?width=0.8)





















